サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1513887

インスリンデリバリーシステムの世界市場

Insulin Delivery Systems

出版日
ページ情報
英文 272 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.55円
インスリンデリバリーシステムの世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 272 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

インスリンデリバリーシステムの世界市場は2030年までに168億米ドルに達する見込み

2023年に134億米ドルと推定されるインスリンデリバリーシステムの世界市場は、分析期間2023～2030年にCAGR 3.3%で成長し、2030年には168億米ドルに達すると予測されます。本レポートで分析されているセグメントの1つである注射器は、CAGR 3.4%を記録し、分析期間終了時には70億米ドルに達すると予測されています。ペンセグメントの成長率は、分析期間でCAGR 4.3％と推定されます。

米国市場は36億米ドルと推定、中国はCAGR 5.8％で成長予測

米国のインスリンデリバリーシステム市場は2023年に36億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに34億米ドルの市場規模に達すると予測され、分析期間2023～2030年のCAGRは5.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.6%と4.0%と予測されています。欧州では、ドイツがCAGR 1.4%で成長すると予測されています。

インスリンデリバリーシステム-主要動向と促進要因

インスリンデリバリーシステムは、世界中で数百万人が罹患している慢性疾患である糖尿病の管理に不可欠なコンポーネントです。これらのシステムは、血糖値の調整に必要なホルモンであるインスリンを、制御された効率的な方法で投与するように設計されています。インスリンデリバリーシステムには、注射器、インスリンペン、インスリンポンプ、吸入式インスリンのような新しい方法など、様々な種類があります。これらのシステムはそれぞれ、利便性、精度、ユーザーエクスペリエンスの点で異なる利点を記載しています。例えば、インスリンペンは、プレフィルドで持ち運びが容易であるため、多くの患者にとって人気のある選択肢となっています。インスリンポンプは、体内の自然なインスリン分泌に近い持続的なインスリン分泌が可能で、特に1型糖尿病患者にとって有益です。情勢は、医療技術の進歩や患者のニーズに対する深い理解によって絶えず進化しています。

技術革新はインスリンデリバリーシステムの進歩の大きな原動力となっています。最新のインスリンポンプは、持続グルコースモニタリング（CGM）統合、自動インスリン投与（AID）、スマートフォン接続などの高度な機能を備えています。これらの進歩は、より正確で個別化された糖尿病管理を可能にし、低血糖のリスクを低減し、全体的な血糖コントロールを改善します。さらに、投与量を追跡しリマインダーを提供できるスマートインスリンペンの開発は、服薬アドヒアランスと投与精度に関する問題の解決に役立っています。吸入可能なインスリンの採用は、注射に代わる非侵襲的な選択肢を提供し、注射針を嫌う患者にアピールしています。さらに、人工膵臓システムとしても知られるクローズドループシステムの研究も進んでおり、患者の介入を最小限に抑えた完全自動のインスリン投与ソリューションの実現を目指しています。このような技術革新は、糖尿病患者の生活の質を向上させるだけでなく、糖尿病治療の新たな基準ともなりつつあります。

インスリンデリバリーシステム市場の成長は、糖尿病有病率の増加、技術の進歩、糖尿病管理に対する意識の高まりなど、いくつかの要因によってもたらされます。肥満や座りがちなライフスタイルなどの要因による糖尿病、特に2型糖尿病の罹患率の増加は、効率的で使い勝手の良いインスリン送達ソリューションの需要を大幅に拡大しています。技術の進歩により、これらのシステムはより利用しやすく効果的なものとなり、より幅広い患者層を惹きつけています。モバイルアプリやクラウドベースのデータ管理などのデジタルヘルス技術の統合は、患者のエンゲージメントと治療プロトコルの遵守を強化しています。消費者の行動も変化しており、利便性と低侵襲性のオプションが重視され、スマートペンや吸入式インスリンのような革新的な送達方法の採用が推進されています。さらに、糖尿病治療のインフラ整備を目的とした政府の支援政策やイニシアチブが、市場の成長を促進しています。競合情勢としては、ハイテク企業と医療プロバイダーのコラボレーションが顕著であり、イノベーションと市場浸透をさらに加速させています。全体として、インスリンデリバリーシステム市場は、人口動向、技術進歩、進化する患者の嗜好の組み合わせに後押しされ、大幅な拡大が見込まれています。

調査対象企業の例（全32社）

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • Wockhardt Ltd.
  • Ypsomed AG

目次

第1章 調査手法

第2章 エグゼクティブ概要

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の展望

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他の欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他のアジア太平洋
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他のラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他の中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-6283

Global Insulin Delivery Systems Market to Reach US$16.8 Billion by 2030

The global market for Insulin Delivery Systems estimated at US$13.4 Billion in the year 2023, is expected to reach US$16.8 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Syringes, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$7.0 Billion by the end of the analysis period. Growth in the Pens segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 5.8% CAGR

The Insulin Delivery Systems market in the U.S. is estimated at US$3.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Insulin Delivery Systems - Key Trends and Drivers

Insulin delivery systems are a critical component in the management of diabetes, a chronic condition affecting millions of people worldwide. These systems are designed to administer insulin, a hormone necessary for regulating blood glucose levels, in a controlled and efficient manner. There are various types of insulin delivery systems, including syringes, insulin pens, insulin pumps, and newer methods like inhalable insulin. Each of these systems offers different advantages in terms of convenience, precision, and user experience. Insulin pens, for example, are prefilled and easy to carry, making them a popular choice for many patients. Insulin pumps provide continuous insulin delivery, closely mimicking the body’s natural insulin release, which is particularly beneficial for individuals with type 1 diabetes. The landscape of insulin delivery systems is continuously evolving, driven by advancements in medical technology and a deeper understanding of patient needs.

Technological innovation has been a significant driver in the advancement of insulin delivery systems. Modern insulin pumps are now equipped with advanced features such as continuous glucose monitoring (CGM) integration, automated insulin delivery (AID), and smartphone connectivity. These advancements allow for more precise and personalized diabetes management, reducing the risk of hypoglycemia and improving overall glycemic control. Additionally, the development of smart insulin pens, which can track doses and provide reminders, is helping to address issues related to adherence and dosing accuracy. The introduction of inhalable insulin offers a non-invasive alternative to injections, appealing to patients who are needle-averse. Furthermore, research into closed-loop systems, also known as artificial pancreas systems, is ongoing, with the goal of creating fully automated insulin delivery solutions that require minimal patient intervention. These innovations are not only improving the quality of life for diabetes patients but are also setting new standards in diabetes care.

The growth in the insulin delivery systems market is driven by several factors, including the increasing prevalence of diabetes, technological advancements, and a growing awareness of diabetes management. The rising incidence of diabetes particularly type 2 diabetes, due to factors such as obesity and sedentary lifestyles, has significantly expanded the demand for efficient and user-friendly insulin delivery solutions. Technological advancements have made these systems more accessible and effective, attracting a broader patient base. The integration of digital health technologies, such as mobile apps and cloud-based data management, is enhancing patient engagement and adherence to treatment protocols. Consumer behavior is also shifting, with a greater emphasis on convenience and minimally invasive options, driving the adoption of innovative delivery methods like smart pens and inhalable insulin. Additionally, supportive government policies and initiatives aimed at improving diabetes care infrastructure are facilitating market growth. The competitive landscape is marked by collaborations between tech companies and healthcare providers, further accelerating innovation and market penetration. Overall, the insulin delivery systems market is poised for significant expansion, propelled by a combination of demographic trends, technological progress, and evolving patient preferences.

Select Competitors (Total 32 Featured) -

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • Wockhardt Ltd.
  • Ypsomed AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Insulin Delivery Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Throws the Spotlight on Insulin Delivery Systems
    • Technological Advancements Propel Growth in Smart Insulin Delivery Devices
    • Increasing Adoption of Continuous Glucose Monitoring (CGM) Systems Expands Addressable Market Opportunity
    • Integration of Digital Health Technologies Strengthens Business Case for Advanced Insulin Delivery Solutions
    • Development of Automated Insulin Delivery (AID) Systems Boost Innovation
    • Non-Invasive Delivery Methods, Such as Inhalable Insulin, Drive Adoption among Needle-Averse Patients
    • Enhanced Smartphone Connectivity and Mobile App Integration Spurs Growth in User Engagement
    • Personalized Diabetes Management Generates Demand for Customized Insulin Delivery Solutions
    • Research into Closed-Loop Systems and Artificial Pancreas Technology Throws the Spotlight on Future Trends
    • Increased Focus on Minimally Invasive Options Expands Addressable Market Opportunity
    • Consumer Shift towards Convenience and Ease of Use Drives Adoption of Innovative Insulin Delivery Methods
    • Enhanced Data Management and Cloud-Based Solutions Generates Demand for Integrated Insulin Delivery Systems
    • Rising Incidence of Type 2 Diabetes among Younger Populations Influences Market Dynamics
    • Improving Quality of Life for Diabetes Patients Sustains Growth in Advanced Insulin Delivery Technologies
    • Evolution of Smart Insulin Pens and Dose Tracking Technologies Strengthens Business Case for Precision Medicine
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Insulin Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Insulin Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pen needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pen needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Pen needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Homecare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Ambulatory Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Insulin Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Insulin Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • INDIA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Insulin Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Insulin Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • AFRICA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030

IV. COMPETITION